Rafael Holdings Inc Ordinary Shares - Class B RFL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.27
- Day Range
- $2.15–2.36
- 52-Week Range
- $1.12–3.96
- Bid/Ask
- $2.00 / $2.29
- Shares Outstanding
- 52.00M
- Market Cap
- $115.96M
- Volume/Avg
- 124,977 / 187,229
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 122.00
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
- Sector
- Real Estate
- Industry
- Real Estate Services
- Stock Style Box
- Small Value
- Total Number of Employees
- 23
- Website
- https://www.rafaelholdings.com
Valuation
|
Metric
|
RFL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.69 |
Price/Sales | 122.00 |
Price/Cash Flow | — |
Price/Earnings
RFL
Financial Strength
|
Metric
|
RFL
|
|---|---|
Quick Ratio | 2.79 |
Current Ratio | 3.16 |
Interest Coverage | −65.04 |
Quick Ratio
RFL
Profitability
|
Metric
|
RFL
|
|---|---|
Return on Assets (Normalized) | −31.81% |
Return on Equity (Normalized) | −39.80% |
Return on Invested Capital (Normalized) | −38.69% |
Return on Assets
RFL
Real Estate Services Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| CBRE Group Inc Class A
CBRE
| LOCK|d^y&ljL | LOCK|?%H>? | $41B | |||
| PT DCI Indonesia Tbk Ordinary Shares
DITPF
| — | LOCK|&@Lfq | $26B | |||
| Sumitomo Realty & Development Co Ltd
SURDF
| — | LOCK|W#g | $21B | |||
| Sumitomo Realty & Development Co Ltd ADR
SURYY
| — | LOCK|?#! | $21B | |||
| Vonovia SE
VNNVF
| — | LOCK|#YP | $21B | |||
| Vonovia SE ADR
VONOY
| — | LOCK|NVn | $21B | |||
| KE Holdings Inc ADR
BEKE
| LOCK|@^pmTh | LOCK|#ktJ | $17B | |||
| Jones Lang LaSalle Inc
JLL
| LOCK|>%CS#>g | LOCK|$zXC | $15B | |||
| CoStar Group Inc
CSGP
| LOCK|b^YG^b@ | LOCK|?^lZ | $12B | |||
| Cushman & Wakefield Ltd
CWK
| LOCK|kYjb@& | LOCK|^Fl | $3B |
United States